Research funder · United States
Michael J. Fox Foundation for Parkinson's Research
Non-profit organization in the USA
- Grants since 2016
- 1 275
- Awarded, last 5 years (where amounts are published)
- —
- Funded works, last 5 years
- 3 085
- Funded works, all time
- 6 716
Grants
2026 · research · Bridge Funding for Disrupted Neurodegenerative Research Grant Program
Dissecting Non-canonical Basal Ganglia Output Circuitry Modulating Movement
Rebekah Evans · Georgetown University Medical Center
2025 · research · Research Grant
Knowledge of Parkinson’s Disease and Impact of an Educational Intervention in the Somali Community in King County
Raima Mahmuda Amin · University of Washington
2025 · research · Parkinson’s Disease Therapeutics Pipeline Program
ACT-02 as a Disease-modifying Therapy for Parkinson’s
Roger Prades · Accure Therapeutics
2025 · research · Seed Amplification Assay Innovation Program
Quantitative Real-Time Alpha-synuclein Seed Detection by SeRAS®
Christiane Ritter · Prosperodes Gmbh
2025 · research · Summer 2025 RFP: Accelerating Biological Understanding and Translational Approaches for PD Program - Biology
Treatment of APOE4-associated Cognitive Decline in Parkinson’s Disease by an Adeno-associated Virus Coding for the Combined APOE2 and APOE-Christchurch Variants
Caner Gunaydin · Weill Cornell Medicine
2025 · research · T2T Validation - Endolysosomal Targets
Development of Translational Biomarkers for TRPML1 Target Engagement in Intact Whole Human Parkinson’s Disease Brains
Paul D. Wes · Bexorg
2025 · research · Research Grant
Validation of the Usability of Patient-specific Midbrain Organoids for LRRK2 Drug Discovery in Parkinson’s Disease
Jens Christian Schwamborn · University of Luxembourg
2025 · research · Seed Amplification Assay Innovation Program
Quantification of Seed Competent Alpha-synuclein in Body Fluids
Christopher Miles Morris · Newcastle University
2025 · research · Neuronal Synuclein Disease Endotypes 2024
Characterizing Molecular Subtypes in Parkinson’s Disease and Lewy Body Dementia
Pieter Jelle Visser · Maastricht University, Amsterdam University Medical Center
2025 · research · Research Grant
Development of a Tau Oligomerization Inhibitor for the Treatment of Parkinson’s Disease
Alan J. Cross · Psy Therapeutics, Inc
2025 · research · T2T Validation - Endolysosomal Targets
Development of in Vivo Biomarkers for TRPML1 Target Engagement and Analysis of Therapeutics
Leon Murphy · Casma Therapeutics (United States)
2025 · research · Research Grant
Characterization of Research Antibodies for Parkinson’s Community-nominated Targets
Carl Laflamme · McGill University
2025 · research · Research Grant
Assessment of Artificial Intelligence (AI) and Blood-Brain Barrier Technology
Beko Binder · Clearview Healthcare Partners
2025 · research · iPSC Phenotyping Environmental Exposure Program
Screening the Functional Impact of Environmental Chemicals on Human Neurons and Astrocytes in Culture
Cedric Bardy · Flinders University
2025 · research · Research Grant
Fostering Knowledge of Gait in PD Through a Multifaceted Dissemination Approach
Anat Mirelman · Aviv University
2025 · research · Accelerating Biological Understanding and Therapeutic Translation for PD-Biology
Elucidating the Role of PINK1 and PRKN in Cell Type-specific Responses to Alpha-synuclein Pathology
Kelly Lynn Stauch · University of Nebraska Medical Center
2025 · research · Neuronal Synuclein Disease Endotypes 2024
Using the Biopark Cohort to Study Neuronal Synuclein Disease Types
Per Svenningsson · Karolinska Institutet
2025 · research · Research Grant
Modeling Parkinson’s Disease in Pre-clinical Models and Models Via Overexpression of Irregular-type and Mutant Alpha-synuclein
Michael Hill · Atuka Inc.
2025 · research · Fall 2025 RFP: Accelerating Biological Understanding and Therapeutic Translation for Parkinson’s Disease Program-Biomarkers
Use of CapScan as a Non-invasive Tool for Intestinal Fluid Alpha-synuclein and Gut Biomarker Detection in Patients with Parkinson’s Disease
Dari Shalon · Envivo Bio Inc.
2025 · research · Biomarkers to Support Therapeutic Trials Program
Ultra-sensitive Quantification of Phosphorylated LRRK2 in Biofluids from Clinical Trials of Therapeutic Candidates
Hardy J. Rideout · Biomedical Research Foundation of the Academy of Athens
2025 · research · Research Grant
Dynamic Microsimulation of Parkinson’s Disease: Evaluating Lifecourse Impacts of Disease Modifying Therapies (VALUE-PD)
Julie Zissimopoulos · University of Southern California
2025 · research · Parkinson’s Disease Therapeutics Pipeline Program
Development of OT-1xx2, a Novel Small Molecule TrkB Activator, for the Treatment of Parkinson’s Disease
Alleyn Plowright · Pangea Botanica Ltd
2025 · research · Seed Amplification Assay Innovation Program
Blood-based Same-day Nano-QuIC for Rapid Detection of Misfolded Alpha-synuclein in Parkinson's Disease
Sang-Hyun Oh · University of Minnesota
2025 · research · T2T Validation - NOD2
Modulating Levels of NOD2 Ligands in the Gut Microbiota to Dampen Neuro-inflammation in Parkinson’s Disease
Dana Philpott · University of Toronto
2025 · research · Parkinson’s Disease Therapeutics Pipeline Program
IND-enabling Studies of a Promising USP30 Inhibitor as Disease-modifying Therapy for Parkinson's Disease
Bahareh (Spring) Behrouz · Vincere Biosciences Inc
2025 · research · iPSC Phenotyping Environmental Exposure Program
Assessing PD-relevant Toxicants on Neurons and Microglia and their Crosstalk
Mark Cookson · National Institute on Aging
2025 · research · Parkinson’s Disease Therapeutics Pipeline Program
Assessment of Psilocybin Therapy for Treatment of Depression in Parkinson’s Disease
Ellen Bradley · University of California, San Francisco
2025 · research · Seed Amplification Assay Innovation Program
A Robust, Quantitative SAA and its Clinical Application
Wolfgang Petrich · Roche (Switzerland)
2025 · research · Research Grant
Enhancing Recruitment of Individuals Traditionally Underrepresented in Parkinson’s Disease Research into the SPARX3 Clinical Trial
Daniel M. Corcos · Northwestern University
2025 · research · Research Grant
Identifying Longitudinal Measures of Parkinson’s Disease Progression Using Structured and Unstructured Electronic Health Record Data
Michael J. Miller · Kaiser Permanente
2025 · research · Accelerating Biological Understanding and Therapeutic Translation for PD-Biomarkers
Dried Blood Spot PNPO Activity as a Biomarker for the Stratification of Parkinson's Disease
Julia Catherine Fitzgerald · Hertie Institute for Clinical Brain Research
2025 · research · Accelerating Biological Understanding and Therapeutic Translation for PD-Biology
Targeting Mitochondrial Complex I in Parkinson’s Disease
Navdeep S. Chandel · Northwestern University
2025 · research · T2T Validation - NOD2
Characterizing NOD2 Genetic Landscape Driving Risk of Parkinson’s Disease
Inga Peter · Icahn School of Medicine at Mount Sinai
2025 · research · Parkinson’s Disease Therapeutics Pipeline Program
Development of Small Molecule Proteasome Activators for the Treatment of Parkinson's Disease
Diogo R. Feleciano · Booster Therapeutics
2025 · research · Research Grant
Analysis of a Potential Alpha-synuclein PET Tracer (18F-FD4) in HC, PD and MSA
Roger Gunn · Xing Imaging – A Xing Imaging Company
2025 · research · Parkinson’s Disease Therapeutics Pipeline Program
Isoform Specific Suppression of dIRE-SNCA with an ASO
Ian Peikon · Cajal Therapeutics
2025 · research · Research Grant
Measurement of 1-deoxysphingolipids in Parkinson’s Disease Plasma
Craig J. Justman · Ceralink Therpeutics
2025 · research · Parkinson’s Disease Therapeutics Pipeline Program
Developing VDAC1 Oligomerization Inhibitor for Treating Parkinson’s Disease
Yotam Nisemblat · X-tosis, Inc.
2025 · research · Accelerating Biological Understanding and Therapeutic Translation for PD-Biology
GBA1 Consortium: Joint Analysis to Inform Clinical Trials
Kathrin Brockmann · Department Of Neurodegeneration, Hertie-institute For Clinical Brain Research
2025 · research · Research Grant
SUPPLEMENT: Empowering Community Health Workers in Clinical Research: A Proposal to Enhance the MJFF Clinical Research Training Modules with Multimedia for Greater Impact
Aaron Sylvan Lord · NYU Langone Health